Wednesday, 22 January 2020
Researchers have found how an antibiotic used to treat a debilitating gut infection stays put inside the body giving it time to effectively treat the problem, a discovery that will pave the way for the development of more effective antibiotic treatments to fight superbugs.
PE (pseudomembranous colitis) is a debilitating inflammation of the colon caused by infection with the microbe Clostridium difficile (andsometimesStaphylococcus aureus). The sugar- or carbohydrate-containing antibiotic known as vancomycin is taken by mouth to kill the infecting microbe.
To be effective, vancomycin needs to stay in the GI tract (gut) close to where it is needed and not be diluted away or lost through the lining of the gut and into the bloodstream. A multi-disciplinary team of scientists at the Universities of Nottingham and Leeds have now shown this ‘staying put’ mechanism is precisely what happens and that it can occur in an unexpected way.
Forming a formidable barrier
The research, published today in Scientific Reports shows that protein-carbohydrate molecules of the gut called mucins provide a formidable barrier helping to prevent the drug escaping using a unique mechanism of formation of large molecular complexes or clumps. The antibiotic and mucins join together to form a mucoadhesive complex, likely trapping the antibiotic within large complexes. It is the trapped vancomycin which the scientists believe may lead to delayed transit of the antibiotic leading to prolonged exposure of the antibiotic to the infectious C. difficile.
Vancomycin is a precious 鈥榣ast-line鈥� antibiotic in the clinician鈥檚 arsenal of therapies to fight several important pathogens including MRSA, pneumonia, as well as C. difficile. The clumping effect with gut mucins revealed in our study not only gives new information about what may happen when the antibiotic is given orally, but might also provide new insights into its behaviour when infused into patients suffering from other life-threatening infections.
The findings also fit with other studies which show that oral vancomycin produces high levels of vancomycin resistance amongst some gut bacteria (VRE), contributing to the generation of antimicrobial resistance (a serious concern); the clumping/ complexation phenomenon may therefore provide the first explanation of a mechanism by which this VRE generation occurs. But the benefits of taking oral vancomycin at the right time and when appropriate still outweigh any negative generation of antimicrobial resistance, and the study highlights that it is wise to take vancomycin when your GP advises it is good to do so.
The antibiotic vancomycin is a truly remarkable molecule 鈥� a drug with its own mucoadhesive or sticky property which slows its transit through the gut right down giving maximum therapeutic effect and minimizing unused vancomycin being returned to the environment. If scientists are going to win the fight against anti-microbial resistance, joint institutional and interdisciplinary approaches like this successful one are going to prove crucial.
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.